FOLFIRI or mFOLFOX6 in Adjuvant Chemotherapy in Advanced Colorectal Cancer
the aim of this study is to observe the effect of irinotecan-based regimen in patients with advanced colorectal cancer.
Colorectal Cancer
DRUG: Oxaliplatin|DRUG: Irinotecan
disease-free survival（DFS）, The investigator will follow up all the enrolled patients. The difference of 3-year-DFS between two groups will be compared., 3-year disease-free survival rate
overall survival(OS), The 5-year survival rate will be the secondary end point. The investigator will follow up the patients and campare the difference of 5-year-OS between the two groups., 5-year survival
the aim of this study is to observe the effect of irinotecan-based regimen in patients with advanced colorectal cancer.